Global Newborn Screening Market

1. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 The GlobalNewborn Screening Market- Industry Trends & Forecast Report 2027 View report Sample report Press release Summary Global Newborn Screening Market, By Product Type (Consumables [Assay Kits & Reagents, and Other Consumables]; By Instruments (Pulse Oximeter, and Newborn Hearing Screening [Accessories, and Devices, and Other Instruments]); By Test Type (Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), and Other Test Types); By Technology (Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, and Other Technologies); By End-User (Hospitals, Diagnostic Centres, and Other End Users); By Region (North America, Europe, Asia-Pacific, South America, Middle East, and Africa) Trend Analysis, Competitive Market Share & Forecast, 2017-2027 A study recently conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global newborn screening market was worth USD 812.1 million in 2020. The data gathered in the study suggest that the market is further projected to reach USD 1,479.4 million by 2027, at a CAGR of 9.3% during the forecast period (2021-2027). The global newborn screening market is being driven by the rising prevalence of newborn disorders,high birth rates in an emerging market, initiatives by world organizations to ensure child care, and recent developments and innovations to protect newborns. Furthermore, the government, as well as non-government bodies have been taking initiatives to facilitate mother & child care besides

2. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 introducing reimbursement policies, which the main trends driving the market growth. The GlobalNewborn Screening Market- Industry Trends & Forecast Report 2027 The global newborn screening market was worth USD 812.1 million in 2020. The data gathered in the study suggest that the market is further projected to reach USD 1,479.4 million by 2027, at a CAGR of 9.3% during the forecast period (2021-2027). The rising prevalence of newborn disorders, such as congenital diseases, and neonatal diseases, along with increasing healthcare budgets across the globe, are driving the market growth. The global newborn screening market is also expected to grow due to technical advancements in the field of medical science and carious diagnostic screening procedures for the early detection of disorders. Furthermore, the government and non-governmental organizations are taking up initiatives to improve mother-child care, which is doubling the number of newborn screening programs around the world. Additionally, favorable reimbursement policies in several countries are also expected to fuel the growth of the global newborn screening market in the coming years. Global Newborn Screening Market Overview Newborn screening is a process of detecting disorders/ diseases in newborn babies by using specialized devices, consumables, instruments, etc. These screening procedures help to diagnose diseases in newborns. The increasing cases of newborn diseases have been propelling the newborn screening market growth. Government support coupled with non-governmental organizations’ initiatives for mother & child care has pushed the newborn screening market growth to the optimum level. The global newborn screening market is being driven due to high concerns for the early detection of diseases/disorders in newborns. Global Newborn Screening Market Trend Growth Drivers Rising Prevalence of Newborn Disorders The global newborn screening market is experiencing rapid growth as frequent cases of infant-related disorders are being recorded. With the rising newborn diseases, many key players have raised awareness and support for using advanced screening instruments for early diagnosis. Hearing, metabolic, and hormonal disorders and critical congenital heart diseases are a few major disorders prevalent in newborns. The early diagnosis of such diseases can help the doctors to treat them effectively. WHO (World Health Organization) in its report published in 2020 claimed that children dying within the first 28 days of birth, have suffered from diseases due to lack of quality care at the time of birth or skilled care and treatment immediately post-birth. High Birth Rates in Emerging Market Following the high-natality rates in some countries like India, China, Brazil, etc. the risk for newborn diseases has also increased, which in turn has created

3. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 lucrative opportunities for the global newborn screening market. According to the UN, India records 25 million births each year which is nearly one-fifth of the global annual childbirths. The high birth rate and the accessible newborn screening procedures in public hospitals indicate an increasing demand for products and consumables. Moreover, countries like Hypothyroidism (CH), Phenylketonuria (PKU), and a hearing test by including them under national screening programs. China have mandated Congenital Market Restraints Poor Healthcare Facilities and Infrastructure One of the major concerns across the global newborn screening market is related to poor healthcare infrastructure & scarcity of skilled professionals. The coronavirus outbreak has depicted several shortcomings in healthcare systems even in emerging economies. Moreover, many countries have recorded falling GDP due to the global economic crisis, which has ultimately caused lower spending on healthcare. Moreover, inaccuracy and low precision of the devices, coupled with the scarcity of skilled professionals, are further restraining the market growth. However, several market players are also developing new models to enhance the precision and accuracy of the kits and instruments. Impact of COVID-19 The COVID-19-induced pandemic has affected practically every industry around the world. Due to the high infection rates and severe impact on public health systems, several countries had to enforce nationwide lockdowns, which significantly impacted industrial supply chains, trade, and related services. The pandemic, on the other hand, had a negligible influence on the global newborn screening market. Soon after the outbreak of the pandemic, strict restrictions were put in place to monitor infant health and safeguard neonates against COVID-19. Many diagnostic laboratories and government agencies have also sought to raise health awareness among parents. Global Newborn Screening Market by Product Type Based on the product type, the global newborn screening market is divided into two categories namely consumables, & instruments. Consumables are further classified into assay kits & reagents, and other consumables. On the other hand, the instrument section is divided into three sections, namely pulse oximeter, newborn hearing screening, which comprises different devices and accessories, and other instruments. The consumables segment accounts for the largest market share due to the constant demand for consumables in newborn screening. Also, increasing newborn disease prevalence and rising health concerns for infants across the globe are the major driving factors that support the growth of consumables.

4. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 Global Newborn Screening Market by Test Type Based on the test type, the global newborn screening market is divided into four main categories- dried blood spot, hearing screening, critical congenital heart defect (CCHD), and other test types. Different test types are used for different purposes. Due to the wide acceptance of dry blood spot tests for screening disorders, and its ability to diagnose metabolic, hormonal, and genetic disorders in the newborn, the dried blood spot segment dominates the market. A dried blood spot is also called a heel-stick as the blood is collected from the heel of a newborn. Global Newborn Screening Market by Technique Based on techniques, the global newborn screening market is divided into the following segments- tandem mass spectrometry, pulse oximetry, enzyme-based assays, DNA assays, and other technologies. Among these, the enzyme-based assays, also known as immune assays, dominate the global newborn screening market. This is due to the wide acceptance of these assays for screening disorders in newborns.This screening procedure implies enzyme-linked immunosorbent assays (ELISA), which help to detect antigens or antibodies by producing a color change. This test is used to detect any disorder that might have been transferred from mother to child during pregnancy. Global Newborn Screening Market by End-User Based on end-users, the global newborn screening market is fragmented into diagnostics centers, hospitals, and other end users. Hospitals dominate the newborn screening industry since hospitals are where most babies are born. Moreover, hospitals can also detect and diagnose any complications that might have transferred from mother to child immediately after the child's birth. Diagnostic centres, on the other hand, are only equipped to provide screening facilities related to different disorders. They provide pathological and radiological testing, along with a doctor to analyze, and verify the reports. Global Newborn Screening Market Regional Insights Based on regions, the global newborn screening market is segmented into North America, Europe, Asia-Pacific, South America, Middle East, and Africa. Among these regions, North America owns the largest market share due to the growing prevalence of congenital disorders and mandatory testing in all the states of the nation. Additionally, the rising demand for advanced screening systems due to the increasing incidence of newborn disorders, favorable reimbursement policies, and a presence of key players in the region have fueled the global newborn screening market in North America. Additionally, the Asia Pacific is anticipated to witness the fastest growth. This can be attributed to high natality rates, increasing screening rates, and rising awareness regarding the early diagnosis of severe disorders in infants.

5. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 Competitive Landscape The global newborn screening market is a concentrated market, with several key players and a diverse range of products. Manufacturers are continually focusing on innovation to produce neonatal genetic screening technologies and kits for the early detection of diseases in newborns. This is expected to further drive the global newborn screening market. Some of the key players in the market are Natus Medical Incorporated, AB Sciex, Masimo Corporation, GE Healthcare, Medtronic Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., ZenTech SA, Demant A/S, Waters Corporation, Trivitron Healthcare, Thermo Fisher Scientific, Hill-Rom Holdings, Inc., and other prominent players. Recent Developments In January 2021, NIPD Genetics announced the launch of an expanded neonatal genetic screening test for newborns, infants, and children by the name Orean. In September 2020, American global corporation,PerkinElmer, attained approval for EONIS screening assay. The approval will allow the company to integrate its newborn test for SCID (severe combined immunodeficiency), SMA (spinal muscular atrophy), and XLA (X-linked agammaglobulinemia) in newborns. Scope of the Report:   Attribute Details Years Considered Historical data – 2017-2020 Base Year – 2020 Forecast – 2021 – 2027 Facts Covered Revenue in USD Million Market Coverage The U.S., Canada, Germany, Italy, U.K., France, Spain, Rest of Europe, Japan, China, India, South Korea, Australia, Rest of Asia-Pacific, Brazil, Mexico, Argentina, etc. Product/Service Segmentation Key Players By Product, By Type, By Test, By Technique, By End- User, and By Region AB Healthcare, Masimo Corporation, Medtronic Inc., Natus Medical Incorporated, PerkinElmer Healthcare, ZenTech SA, Demant Corporation, Thermo Fisher Holdings, Inc., and other prominent players. Sciex, Bio-Rad Laboratories Inc., GE Inc., Trivitron A/S, Waters Scientific, Hill-Rom

6. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 By Product Type Consumables oAssay Kits & Reagents oOther Consumables Instruments oPulse Oximeter oNewborn Hearing Screening Accessories Devices oOther Instruments By Test Type Dried Blood Spot Hearing Screening Critical Congenital Heart Defect (CCHD) Other Test Types By Technology Tandem Mass Spectrometry Pulse Oximetry Enzyme Based Assays DNA Assays Other Technologies By End-User Hospitals Diagnostic Centers Other End Users By Region North America Europe

7. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027 The Asia-Pacific Latin America The Middle East and Africa About us Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade- off. Delivering quality insights into several product or service markets within the timeline as per the needs of the clients has earned BWC an excellent reputation among clients. BWC strives to provide timely and accurate digital market intelligence services for making your business endeavours successful. For more information, kindly visit our Website www.blueweaveconsulting.com contact us info@blueweaveconsulting.com

8. Global Newborn Screening Market Growing Dynamically—Projected to Reach worth USD 1,479.4 Million in 2027